论文部分内容阅读
免疫异常在头颈癌病人中较支气管肺癌、乳腺癌、宫颈癌、结肠癌和膀胱癌病人更有意义。头颈癌病人体液免疫的变化较有关B淋巴细胞的细胞反应要弱些,血清IgG和IgM含量无明显改变,仅血清IgA有增高。血清IgE含量在其它部位的癌症病人已有各种报道,而头颈癌病人的这类免疫球蛋白却几乎很少受到注意。IgD含量在头颈癌、口腔癌病例中也还未被研究。作者检测了口腔癌病人血清IgG、IgA、
Immune abnormalities are more significant in head and neck cancer patients than in patients with bronchial lung cancer, breast cancer, cervical cancer, colon cancer, and bladder cancer. The changes of humoral immunity in patients with head and neck cancer were weaker than those in B lymphocytes. There was no significant change in serum IgG and IgM levels. Only serum IgA increased. There have been various reports of cancer patients with other IgE sites in their serum IgE levels. However, this type of immunoglobulin in head and neck cancer patients has received little attention. IgD levels have not been studied in head and neck and oral cancer cases. The authors tested serum IgG, IgA, and oral cancer patients.